Snezana is a myeloma patient the president of the Serbian Association of Myeloma Patients (Udruženje obolelih od multiplog mijeloma Srbije). She spent years working as a business consultant covering finance, regulatory frameworks, international trade and distribution and also served as finance director with extensive experience at board level. Snezana’s mission is sharing knowledge, experiences, advocacy strategies, and developing collaboration between different EU regions to improve the capacities of CEE country myeloma associations.
EMA CHMP gives positive opinion on isatuximab combination for newly diagnosed myeloma patients
On 14 November 2024, the Committee for Medicinal Products for Human Use (CHMP) recommended adding a new indication for isatuximab, a monoclonal antibody treatment marketed by Sanofi as Sarclisa ®.…